Everest Medicines Announces Strategic Business Partnership with Global Technology Company Tencent
SHANGHAI, July 12, 2021 / PRNewswire / – Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on the development and commercialization of transformative pharmaceuticals that meet the critical unmet medical needs of patients in Greater China and other parts of Asia, today announced that it has entered into a strategic business partnership with Tencent, one of the world’s largest tech companies, to explore new ways to optimize meaningful digital engagement with patients and healthcare providers.
“As part of our preparations to become a commercial organization, we are focusing on establishing key partnerships and creating an innovative and comprehensive technology solution offering to engage and connect patients, healthcare providers, payers and other key industry stakeholders, ”said Kerry Blanchard, MD, PhD, CEO of Everest Medicines. “This partnership with Tencent, a global technology powerhouse, is a critical part of our overall business strategy as it will enable us to leverage the power of digital transformation, technology and data to strengthen our market position and ensure patients and providers health care in Greater China have better access to the information and medicines they need.
As part of this partnership, Medicines from Everest explore a number of capabilities and potential solutions with Tencent, including ways to engage patients and healthcare professionals in disease awareness, especially for various cancers, kidney diseases and serious infectious diseases, which tend to have a disproportionate impact on people in the community. Greater China region and have limited treatment options, resulting in significant unmet medical needs. In addition, the companies will explore options to create a one-stop patient management ecosystem that covers disease management, from diagnosis to treatment and outcome, as well as ways to leverage artificial intelligence tools and ‘business intelligence to better identify customer profiles and improve treatment adoption.
About Everest Medicines
Everest Medicines is a biopharmaceutical company focused on the development and commercialization of transformative pharmaceutical products that meet the critical unmet medical needs of patients in Greater China and other Asian markets. The Everest Medicines leadership team has deep expertise and extensive experience in high quality clinical development, regulatory affairs, CMC, business development and operations in both China and with the world’s leading pharmaceutical companies. Everest Medicines has built a portfolio of eight potentially global first-class or first-class molecules, many of which are at an advanced stage of clinical development. The therapeutic areas of interest of the Company include oncology, autoimmune diseases, cardio-renal diseases and infectious diseases. For more information, please visit their website at www.everestmedicines.com
Tencent uses technology to enrich the lives of Internet users. Communication and social services, Weixin and QQ, connect users with each other and with digital content and services, both online and offline, making their lives more convenient. Targeted advertising service helps advertisers reach hundreds of millions of consumers in China. Our FinTech and business services support the commercial growth of our partners and support their digital evolution. Tencent invests heavily in talent and technological innovation, actively promoting the development of the Internet industry. Tencent Was founded in Shenzhen, china, in 1998. Actions of Tencent (00700.HK) are listed on the main board of the Stock Exchange Hong Kong.
SOURCE Everest Medicines